Rahn Bailey
Psychiatry · New Orleans, LANPI 1063565737
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,090 of the $7,910 with a category attached, or 64.4%. 21 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 25.5% of the total. Reporting peaked in 2021 at $2,361 and has fallen 58.9% since, to $971 in 2025. Among psychiatry clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $75.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$2K
- Johnson & Johnson$1K
- Sunovion Pharmaceuticals Inc.$1K
- Acadia Pharmaceuticals Inc$615
- Teva Pharmaceuticals USA, Inc.$422
- Sage Therapeutics, LLC$385
- plus $2K from 15 others
What the payments were for
- Consulting fees$2,00025%
- Speaking & faculty fees$82010%
- Food & beverage$5,09064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $2,019 |
| Johnson & Johnson | 25 | $1,314 |
| Sunovion Pharmaceuticals Inc. | 9 | $1,164 |
| Acadia Pharmaceuticals Inc | 7 | $615 |
| Teva Pharmaceuticals USA, Inc. | 13 | $422 |
| Sage Therapeutics, LLC | 2 | $385 |
| Otsuka America Pharmaceutical, Inc. | 15 | $298 |
| Alkermes, Inc. | 6 | $216 |
| E.r. Squibb & Sons, L.L.C. | 2 | $206 |
| Biogen | 2 | $171 |
| Neurocrine Biosciences, Inc. | 7 | $160 |
| Axsome Therapeutics, Inc. | 3 | $154 |
| AbbVie | 2 | $141 |
| Luye Pharma (USA) Ltd. | 2 | $140 |
| TG Therapeutics, Inc. | 1 | $125 |
| EMD Serono, Inc. | 1 | $125 |
| Viiv Healthcare Company | 1 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| Lundbeck LLC | 1 | $30 |
| UCB, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA$2,000
- LATUDA$937
- SPRAVATO$803
- NUPLAZID$470
- ARISTADA$208
- LYBALVI$208
- INVEGA SUSTENNA$125
- VRAYLAR$125
- BRIUMVI$125
- ERZOFRI EXTENDED-RELEASE$125
- Mavenclad$125
- Auvelity$109
- COBENFY$108
- AUSTEDO$107
- ARISTADA INITIO$104
How this compares
$7,910 in reported general payments places this provider in the 90th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in New Orleans
- Arwen PodestaNew Orleans$466K
- Andrew MorsonNew Orleans$56K
- James BarbeeNew Orleans$28K
- Neha KansaraNew Orleans$13K
- Erich ConradNew Orleans$9K
- Nick RamandiNew Orleans$8K
- Ashley WeissNew Orleans$8K
- Ravindra ReddyNew Orleans$7K
- Paul PeltsNew Orleans$6K
- Janet BradleyNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.